USE OF A PHARMACEUTICAL CARRIER IN THE PREPARATION OF AN ANTIDIABTIC PHARMACEUTICAL COMPOSITION CONTAINING BERBERINE AND ORYZANOL

Abstract

The present invention relates to the use of a pharmaceutical carrier in the preparation of an antidiabetic pharmaceutical composition. In particular, the present invention relates to the use of a pharmaceutical carrier in the preparation of an antidiabetic pharmaceutical composition, wherein the pharmaceutical carrier consists of well-mixed sesame oil and beeswax, and the antidiabetic pharmaceutical composition consists of oryzanol and berberine hydrochloride as active ingredients, wherein oryzanol is present in an amount of 1-5% by weight, berberine hydrochloride is present in an amount of 5-50% by weight, beeswax is present in an amount of 1-20% by weight, and sesame oil is present in an amount of 40-85% by weight, based on the total weight of the pharmaceutical composition.The present invention further relates to an antidiabetic pharmaceutical composition as above, which is subjected to compression, washing, drying and screening, and filling into a vial to obtain a soft capsule dosage form product. The product has advantages such as stable control of blood glucose, lowering of blood glucose level and blood lipids, protection of liver function, and reduction of gastrointestinal irritation.